DHA 'fish oil' supplements do not seem to slow cognitive, functional decline in Alzheimer's disease
Tuesday, November 2, 2010 - 11:30
in Health & Medicine
Patients with mild to moderate Alzheimer's disease (AD) who received supplementation with the omega-3 fatty acid docosahexaenoic acid (DHA), believed to possibly reduce the risk of AD, did not experience a reduction in the rate of cognitive and functional decline, compared to patients who received placebo, according to a study in the November 3 issue of JAMA, a theme issue on aging.